Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAO1 for Early Self-Treatment of Common Cold
NCT01651715Phase 2Completed
- Sponsor
- Theranos
- Start
- Sep 2012
- Primary completion
- Aug 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of TAO1 in common cold, sponsored by Theranos. Started Sep 2012; status: completed.
02
Drugs
TAO1
03
Conditions
common cold
Beyond the preview
Go deeper on NCT01651715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01651715.